TY - JOUR AU - Bianchini, G. AU - Balko, J. M. AU - Mayer, I. A. AU - Sanders, M. E. AU - Gianni, L. PY - 2016 DA - 2016// TI - Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.66 DO - 10.1038/nrclinonc.2016.66 ID - Bianchini2016 ER - TY - STD TI - Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, et al. Atezolizumab and nab-paclitaxel in advanced triple-negative breast Cancer. N Engl J Med. 2018. ID - ref2 ER - TY - JOUR AU - Vignon, F. AU - Capony, F. AU - Chambon, M. AU - Freiss, G. AU - Garcia, M. AU - Rochefort, H. PY - 1986 DA - 1986// TI - Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein JO - Endocrinology VL - 118 UR - https://doi.org/10.1210/endo-118-4-1537 DO - 10.1210/endo-118-4-1537 ID - Vignon1986 ER - TY - JOUR AU - Foekens, J. A. AU - Look, M. P. AU - Bolt-de Vries, J. AU - Meijer-van Gelder, M. E. AU - Putten, W. L. AU - Klijn, J. G. PY - 1999 DA - 1999// TI - Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients JO - Br J Cancer VL - 79 UR - https://doi.org/10.1038/sj.bjc.6690048 DO - 10.1038/sj.bjc.6690048 ID - Foekens1999 ER - TY - JOUR AU - Ferrandina, G. AU - Scambia, G. AU - Bardelli, F. AU - Benedetti Panici, P. AU - Mancuso, S. AU - Messori, A. PY - 1997 DA - 1997// TI - Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis JO - Br J Cancer VL - 76 UR - https://doi.org/10.1038/bjc.1997.442 DO - 10.1038/bjc.1997.442 ID - Ferrandina1997 ER - TY - JOUR AU - Glondu, M. AU - Liaudet-Coopman, E. AU - Derocq, D. AU - Platet, N. AU - Rochefort, H. AU - Garcia, M. PY - 2002 DA - 2002// TI - Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205657 DO - 10.1038/sj.onc.1205657 ID - Glondu2002 ER - TY - JOUR AU - Vetvicka, V. AU - Benes, P. AU - Fusek, M. PY - 2002 DA - 2002// TI - Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors JO - Cancer Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.cgt.7700508 DO - 10.1038/sj.cgt.7700508 ID - Vetvicka2002 ER - TY - JOUR AU - Laurent-Matha, V. AU - Maruani-Herrmann, S. AU - Prebois, C. AU - Beaujouin, M. AU - Glondu, M. AU - Noel, A. PY - 2005 DA - 2005// TI - Catalytically inactive human cathepsin D triggers fibroblast invasive growth JO - J Cell Biol VL - 168 UR - https://doi.org/10.1083/jcb.200403078 DO - 10.1083/jcb.200403078 ID - Laurent-Matha2005 ER - TY - JOUR AU - Beaujouin, M. AU - Prebois, C. AU - Derocq, D. AU - Laurent-Matha, V. AU - Masson, O. AU - Pattingre, S. PY - 2010 DA - 2010// TI - Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth JO - J Cell Sci VL - 123 UR - https://doi.org/10.1242/jcs.070938 DO - 10.1242/jcs.070938 ID - Beaujouin2010 ER - TY - JOUR AU - Berchem, G. AU - Glondu, M. AU - Gleizes, M. AU - Brouillet, J. P. AU - Vignon, F. AU - Garcia, M. PY - 2002 DA - 2002// TI - Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205745 DO - 10.1038/sj.onc.1205745 ID - Berchem2002 ER - TY - JOUR AU - Pranjol, M. Z. I. AU - Gutowski, N. J. AU - Hannemann, M. AU - Whatmore, J. L. PY - 2017 DA - 2017// TI - Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways JO - Biochim Biophys Acta VL - 1865 UR - https://doi.org/10.1016/j.bbamcr.2017.10.005 DO - 10.1016/j.bbamcr.2017.10.005 ID - Pranjol2017 ER - TY - STD TI - Hasilik A, von Figura K, Conzelmann E, Nehrkorn H, Sandhoff K. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase a precursor towards ganglioside GM2. Eur J Biochem 1982;125(2):317–321. ID - ref12 ER - TY - JOUR AU - Benes, P. AU - Vetvicka, V. AU - Fusek, M. PY - 2008 DA - 2008// TI - Cathepsin D--many functions of one aspartic protease JO - Crit Rev Oncol Hematol VL - 68 UR - https://doi.org/10.1016/j.critrevonc.2008.02.008 DO - 10.1016/j.critrevonc.2008.02.008 ID - Benes2008 ER - TY - JOUR AU - Masson, O. AU - Bach, A. S. AU - Derocq, D. AU - Prebois, C. AU - Laurent-Matha, V. AU - Pattingre, S. PY - 2010 DA - 2010// TI - Pathophysiological functions of cathepsin D: targeting its catalytic activity versus its protein binding activity? JO - Biochimie VL - 92 UR - https://doi.org/10.1016/j.biochi.2010.05.009 DO - 10.1016/j.biochi.2010.05.009 ID - Masson2010 ER - TY - STD TI - Khalkhali-Ellis Z, Hendrix MJ. Two faces of Cathepsin D: physiological Guardian angel and pathological demon. Biology and medicine. 2014;6(2). ID - ref15 ER - TY - JOUR AU - Wolf, M. AU - Clark-Lewis, I. AU - Buri, C. AU - Langen, H. AU - Lis, M. AU - Mazzucchelli, L. PY - 2003 DA - 2003// TI - Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer JO - Am J Pathol VL - 162 UR - https://doi.org/10.1016/S0002-9440(10)63914-4 DO - 10.1016/S0002-9440(10)63914-4 ID - Wolf2003 ER - TY - JOUR AU - Hasan, L. AU - Mazzucchelli, L. AU - Liebi, M. AU - Lis, M. AU - Hunger, R. E. AU - Tester, A. PY - 2006 DA - 2006// TI - Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing JO - J Immunol VL - 176 UR - https://doi.org/10.4049/jimmunol.176.11.6512 DO - 10.4049/jimmunol.176.11.6512 ID - Hasan2006 ER - TY - STD TI - Laurent-Matha V, Huesgen PF, Masson O, Derocq D, Prebois C, Gary-Bobo M, et al. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J. 2012. ID - ref18 ER - TY - JOUR AU - Maynadier, M. AU - Farnoud, R. AU - Lamy, P. J. AU - Laurent-Matha, V. AU - Garcia, M. AU - Rochefort, H. PY - 2013 DA - 2013// TI - Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment JO - Int J Oncol VL - 43 UR - https://doi.org/10.3892/ijo.2013.2095 DO - 10.3892/ijo.2013.2095 ID - Maynadier2013 ER - TY - JOUR AU - Vetvicka, V. AU - Vetvickova, J. AU - Hilgert, I. AU - Voburka, Z. AU - Fusek, M. PY - 1997 DA - 1997// TI - Analysis of the interaction of procathepsin D activation peptide with breast cancer cells JO - Int J Cancer VL - 73 UR - https://doi.org/3.0.CO;2-D DO - 3.0.CO;2-D ID - Vetvicka1997 ER - TY - JOUR AU - Derocq, D. AU - Prebois, C. AU - Beaujouin, M. AU - Laurent-Matha, V. AU - Pattingre, S. AU - Smith, G. K. PY - 2012 DA - 2012// TI - Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.501 DO - 10.1038/onc.2011.501 ID - Derocq2012 ER - TY - JOUR AU - Siintola, E. AU - Partanen, S. AU - Stromme, P. AU - Haapanen, A. AU - Haltia, M. AU - Maehlen, J. PY - 2006 DA - 2006// TI - Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis JO - Brain VL - 129 UR - https://doi.org/10.1093/brain/awl107 DO - 10.1093/brain/awl107 ID - Siintola2006 ER - TY - JOUR AU - Anantaraju, H. S. AU - Battu, M. B. AU - Viswanadha, S. AU - Sriram, D. AU - Yogeeswari, P. PY - 2016 DA - 2016// TI - Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: molecular docking and bioevaluation against triple-negative and triple-positive breast cancers JO - Mol Divers VL - 20 UR - https://doi.org/10.1007/s11030-015-9645-8 DO - 10.1007/s11030-015-9645-8 ID - Anantaraju2016 ER - TY - JOUR AU - Freiss, G. AU - Vignon, F. AU - Rochefort, H. PY - 1988 DA - 1988// TI - Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells JO - Cancer Res VL - 48 ID - Freiss1988 ER - TY - JOUR AU - Saadoun, H. AU - Lamy, P. J. AU - Thezenas, S. AU - Pouderoux, S. AU - Bibeau, F. AU - Montels, F. PY - 2014 DA - 2014// TI - Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer JO - Future Oncol VL - 10 UR - https://doi.org/10.2217/fon.13.177 DO - 10.2217/fon.13.177 ID - Saadoun2014 ER - TY - JOUR AU - Manoir, S. AU - Orsetti, B. AU - Bras-Goncalves, R. AU - Nguyen, T. T. AU - Lasorsa, L. AU - Boissiere, F. PY - 2014 DA - 2014// TI - Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2013.11.010 DO - 10.1016/j.molonc.2013.11.010 ID - Manoir2014 ER - TY - STD TI - Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics 2014;47:5 6 1–32. ID - ref27 ER - TY - JOUR AU - Bourquard, T. AU - Landomiel, F. AU - Reiter, E. AU - Crepieux, P. AU - Ritchie, D. W. AU - Aze, J. PY - 2015 DA - 2015// TI - Unraveling the molecular architecture of a G protein-coupled receptor/beta-arrestin/Erk module complex JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep10760 DO - 10.1038/srep10760 ID - Bourquard2015 ER - TY - JOUR AU - Gyorffy, B. AU - Lanczky, A. AU - Eklund, A. C. AU - Denkert, C. AU - Budczies, J. AU - Li, Q. PY - 2010 DA - 2010// TI - An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-009-0674-9 DO - 10.1007/s10549-009-0674-9 ID - Gyorffy2010 ER - TY - JOUR AU - Turtoi, A. AU - Pauw, E. AU - Castronovo, V. PY - 2011 DA - 2011// TI - Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies JO - Am J Pathol VL - 178 UR - https://doi.org/10.1016/j.ajpath.2010.08.004 DO - 10.1016/j.ajpath.2010.08.004 ID - Turtoi2011 ER - TY - JOUR AU - Philibert, P. AU - Stoessel, A. AU - Wang, W. AU - Sibler, A. P. AU - Bec, N. AU - Larroque, C. PY - 2007 DA - 2007// TI - A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm JO - BMC Biotechnol VL - 7 UR - https://doi.org/10.1186/1472-6750-7-81 DO - 10.1186/1472-6750-7-81 ID - Philibert2007 ER - TY - JOUR AU - Robin, G. AU - Martineau, P. PY - 2012 DA - 2012// TI - Synthetic customized scFv libraries JO - Methods Mol Biol VL - 907 UR - https://doi.org/10.1007/978-1-61779-974-7_6 DO - 10.1007/978-1-61779-974-7_6 ID - Robin2012 ER - TY - JOUR AU - Baldwin, E. T. AU - Bhat, T. N. AU - Gulnik, S. AU - Hosur, M. V. AU - Sowder, R. C. AU - Cachau, R. E. PY - 1993 DA - 1993// TI - Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design JO - Proc Natl Acad Sci U S A VL - 90 UR - https://doi.org/10.1073/pnas.90.14.6796 DO - 10.1073/pnas.90.14.6796 ID - Baldwin1993 ER - TY - JOUR AU - Weiner, G. J. PY - 2015 DA - 2015// TI - Building better monoclonal antibody-based therapeutics JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3930 DO - 10.1038/nrc3930 ID - Weiner2015 ER - TY - JOUR AU - Nimmerjahn, F. AU - Ravetch, J. V. PY - 2012 DA - 2012// TI - Translating basic mechanisms of IgG effector activity into next generation cancer therapies JO - Cancer Immun VL - 12 ID - Nimmerjahn2012 ER - TY - JOUR AU - Hristodorov, D. AU - Fischer, R. AU - Joerissen, H. AU - Muller-Tiemann, B. AU - Apeler, H. AU - Linden, L. PY - 2013 DA - 2013// TI - Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies JO - Mol Biotechnol VL - 53 UR - https://doi.org/10.1007/s12033-012-9531-x DO - 10.1007/s12033-012-9531-x ID - Hristodorov2013 ER - TY - JOUR AU - Zhao, X. AU - Qu, J. AU - Sun, Y. AU - Wang, J. AU - Liu, X. AU - Wang, F. PY - 2017 DA - 2017// TI - Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature JO - Oncotarget VL - 8 ID - Zhao2017 ER - TY - JOUR AU - Safarzadeh, E. AU - Orangi, M. AU - Mohammadi, H. AU - Babaie, F. AU - Baradaran, B. PY - 2018 DA - 2018// TI - Myeloid-derived suppressor cells: important contributors to tumor progression and metastasis JO - J Cell Physiol VL - 233 UR - https://doi.org/10.1002/jcp.26075 DO - 10.1002/jcp.26075 ID - Safarzadeh2018 ER - TY - JOUR AU - Tariq, M. AU - Zhang, J. AU - Liang, G. AU - Ding, L. AU - He, Q. AU - Yang, B. PY - 2017 DA - 2017// TI - Macrophage polarization: anti-Cancer strategies to target tumor-associated macrophage in breast Cancer JO - J Cell Biochem VL - 118 UR - https://doi.org/10.1002/jcb.25895 DO - 10.1002/jcb.25895 ID - Tariq2017 ER - TY - JOUR AU - Scodeller, P. AU - Simon-Gracia, L. AU - Kopanchuk, S. AU - Tobi, A. AU - Kilk, K. AU - Saalik, P. PY - 2017 DA - 2017// TI - Precision targeting of tumor macrophages with a CD206 binding peptide JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-14709-x DO - 10.1038/s41598-017-14709-x ID - Scodeller2017 ER - TY - JOUR AU - Souza-Fonseca-Guimaraes, F. PY - 2016 DA - 2016// TI - NK cell-based immunotherapies: awakening the innate anti-cancer response JO - Discov Med VL - 21 ID - Souza-Fonseca-Guimaraes2016 ER - TY - JOUR AU - Steel, J. C. AU - Waldmann, T. A. AU - Morris, J. C. PY - 2012 DA - 2012// TI - Interleukin-15 biology and its therapeutic implications in cancer JO - Trends Pharmacol Sci VL - 33 UR - https://doi.org/10.1016/j.tips.2011.09.004 DO - 10.1016/j.tips.2011.09.004 ID - Steel2012 ER - TY - JOUR AU - Huang, L. AU - Liu, Z. AU - Chen, S. AU - Liu, Y. AU - Shao, Z. PY - 2013 DA - 2013// TI - A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0083081 DO - 10.1371/journal.pone.0083081 ID - Huang2013 ER - TY - JOUR AU - Vetvicka, V. AU - Vetvickova, J. AU - Fusek, M. PY - 1999 DA - 1999// TI - Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development JO - Breast Cancer Res Treat VL - 57 UR - https://doi.org/10.1023/A:1006238003772 DO - 10.1023/A:1006238003772 ID - Vetvicka1999 ER - TY - JOUR AU - Nimmerjahn, F. AU - Gordan, S. AU - Lux, A. PY - 2015 DA - 2015// TI - FcgammaR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities JO - Trends Immunol VL - 36 UR - https://doi.org/10.1016/j.it.2015.04.005 DO - 10.1016/j.it.2015.04.005 ID - Nimmerjahn2015 ER - TY - JOUR AU - Fuxe, J. AU - Karlsson, M. C. PY - 2012 DA - 2012// TI - TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation JO - Semin Cancer Biol VL - 22 UR - https://doi.org/10.1016/j.semcancer.2012.05.004 DO - 10.1016/j.semcancer.2012.05.004 ID - Fuxe2012 ER - TY - JOUR AU - Georgoudaki, A. M. AU - Prokopec, K. E. AU - Boura, V. F. AU - Hellqvist, E. AU - Sohn, S. AU - Ostling, J. PY - 2016 DA - 2016// TI - Reprogramming tumor-associated macrophages by antibody targeting inhibits Cancer progression and metastasis JO - Cell Rep VL - 15 UR - https://doi.org/10.1016/j.celrep.2016.04.084 DO - 10.1016/j.celrep.2016.04.084 ID - Georgoudaki2016 ER - TY - JOUR AU - Gabrilovich, D. I. AU - Nagaraj, S. PY - 2009 DA - 2009// TI - Myeloid-derived suppressor cells as regulators of the immune system JO - Nat Rev Immunol VL - 9 UR - https://doi.org/10.1038/nri2506 DO - 10.1038/nri2506 ID - Gabrilovich2009 ER - TY - JOUR AU - Ito, R. AU - Takahashi, T. AU - Katano, I. AU - Ito, M. PY - 2012 DA - 2012// TI - Current advances in humanized mouse models JO - Cell Mol Immunol VL - 9 UR - https://doi.org/10.1038/cmi.2012.2 DO - 10.1038/cmi.2012.2 ID - Ito2012 ER -